Sodium Bicarbonate
Sodium Bicarbonate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Sodium Bicarbonate; Generic name: SODIUM BICARBONATE; Manufacturer: Fresenius Kabi USA, LLC.
| Brand name | Sodium Bicarbonate |
|---|---|
| Generic name | SODIUM BICARBONATE |
| Manufacturer | Fresenius Kabi USA, LLC |
| Used for | INDICATIONS AND USAGE: Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate |
| Dosage | DOSAGE AND ADMINISTRATION: Sodium Bicarbonate Injection, USP is administered by the intravenous route. In cardiac arrest, a rapid intravenous dose of 44.6 to 100 mEq may be given initially and continued at a rate of 44.6 to 50 mEq every 5 to 10 minutes if necessary (as indicated by arterial pH and blood gas monitoring) to reverse the acidosis. Caution should be observed in emergencies where very rapid infusion of large quantities of bicarbonate is indicated. Bicarbonate solutions are hypertonic |
| Warnings | WARNINGS: Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention. In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention. The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentr |
| Active ingredient(s) | SODIUM BICARBONATE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ab55004-bb63-436d-ad77-cd3796905370 |